BII Tracker

Research & Education

Credible information, clearly labeled.

A verified library on Breast Implant Illness (BII). Every resource carries an evidence label so you always know what kind of source you're reading, links to its original source, and states plainly what it does — and does not — prove.

Tracker Guides

Written for you · plain language

Short orientation guides from the Tracker. These are educational — not primary sources — and cite authoritative sources for any medical facts.

Source Library

Verified external sources, each carrying an evidence label and a link to its original.

Regulatory / FDA

Information published by regulatory bodies such as the U.S. FDA.

Peer-Reviewed Research

Published, peer-reviewed scientific literature.

Professional / Clinical Guidance

Guidance from authoritative medical or professional societies (e.g., ASPS).

Community-Reported Data

Observational, community-reported experience. Does not establish incidence, prevalence, or causation.

Regulatory / FDA

Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

The FDA's Q&A on BIA-ALCL — a lymphoma of the immune system (not breast cancer) that can develop in the scar tissue and fluid around an implant, with higher risk for textured implants.

BIA-ALCLFDA & Regulatory Information
Professional / Clinical Guidance

Breast Implant-Associated Anaplastic Large Cell Lymphoma (ASPS Patient Summary)

The plastic-surgery society's patient summary of BIA-ALCL — a cancer of the immune system (not breast cancer) linked mainly to textured implants and usually curable when caught early.

BIA-ALCLImaging & Monitoring
Community-Reported Data

Community insights will appear here as the BII Tracker participant cohort grows. We never publish example or manufactured numbers — this section stays empty until real, consented, de-identified data exists.

Breast Implant Illness Tracker provides education and organizational tools only and does not provide medical diagnosis or treatment.